Japan’s MOF official says expects BoJ to steer policy aligned with economy, not influenced by US
A senior official from Japan’s Ministry of Finance on Tuesday declined to comment on recent foreign exchange shifts, adding that expected the Bank of Japan (BoJ) to steer monetary policy aligned with the economy, not influenced by the United States.
Key quotes
Declines to comment on recent forex shifts.
Expects BoJ to steer monetary policy aligned with economy, not influenced by U.S.
Katayama, Bessent talked fx intervention in bilateral meeting, among other issues.
Japan's fiscal policy, latest joint FX intervention among key topics in Katayama, Bessent meeting.
Finmin Katayama detailed conditions for U.S.-Japan joint intervention, factors behind decision to G7 counterparts.
No talks on U.S. bond repurchase at bilateral meeting.
Market reaction
At the time of writing, the USD/JPY pair is up 0.03% on the day at 159.80.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The second wave of energy price increases is looming! European Central Bank’s Lane warns: eurozone inflation will be higher and more persistent
Philip Lane, Chief Economist of the European Central Bank, stated that a new round of high energy prices means inflation in the eurozone will remain elevated for longer than the ECB initially anticipated.
Bitcoin Trades Around $86K as FOMO Hits Highest Level Since 2024
siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions
ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.
Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.
The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.
Crypto prices
More
